| 101234-3 |
Glial nuclear type 1 Ab |
PrThr |
CSF |
Pt |
Ord |
IB |
|
ACTIVE |
Glial nuclear type 1 Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
101234-3 |
|
IB |
|
|
Both |
|
|
|
0 |
Glial nuc type 1 Ab CSF Ql IB |
|
|
|
N |
|
ABS; Aby; AGNA; AGNA-1; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; Cerebral spinal fluid; Cerebrospinal Fl; Glial nuc type 1; i; Immune blot; Immunobl; Immunoblot; Lambert-Eaton myasthenic syndrome; Nuc; Ordinal; Paraneoplastic Antibody; Paraneoplastic syndrome; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serology; Sox1; Sox1 nuclear antigen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; WB; WBLOT; West blot; West blt; Western blot |
2.75 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101235-0 |
Glial nuclear type 1 Ab |
PrThr |
Ser |
Pt |
Ord |
IB |
|
ACTIVE |
Glial nuclear type 1 Ab [Presence] in Serum by Immunoblot |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
101235-0 |
|
IB |
|
|
Both |
|
|
|
0 |
Glial nuc type 1 Ab Ser Ql IB |
|
|
|
N |
|
ABS; Aby; AGNA; AGNA-1; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; Glial nuc type 1; i; Immune blot; Immunobl; Immunoblot; Lambert-Eaton myasthenic syndrome; Nuc; Ordinal; Paraneoplastic Antibody; Paraneoplastic syndrome; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serology; Serum; Sox1; Sox1 nuclear antigen; SR; WB; WBLOT; West blot; West blt; Western blot |
2.75 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101236-8 |
Titin Ab |
PrThr |
CSF |
Pt |
Ord |
IB |
|
ACTIVE |
Titin Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
101236-8 |
|
IB |
|
|
Both |
|
|
|
0 |
Titin Ab CSF Ql IB |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; Cerebral spinal fluid; Cerebrospinal Fl; Immune blot; Immunobl; Immunoblot; Myasthenia gravis; Ordinal; Paraneoplastic neurological syndrome; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Thymoma; WB; WBLOT; West blot; West blt; Western blot |
2.75 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101237-6 |
Titin Ab |
PrThr |
Ser |
Pt |
Ord |
IB |
|
ACTIVE |
Titin Ab [Presence] in Serum by Immunoblot |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
101237-6 |
|
IB |
|
|
Both |
|
|
|
0 |
Titin Ab Ser Ql IB |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; Immune blot; Immunobl; Immunoblot; Myasthenia gravis; Ordinal; Paraneoplastic neurological syndrome; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serology; Serum; SR; Thymoma; WB; WBLOT; West blot; West blt; Western blot |
2.75 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101238-4 |
Spermatozoa.immotile/Spermatozoa^post vasectomy |
NFr |
Semen |
Pt |
Qn |
|
|
ACTIVE |
Spermatozoa Immotile/Spermatozoa in Semen --post vasectomy |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
FERT |
|
101238-4 |
|
|
|
|
Observation |
|
|
|
0 |
Sperm Immotile p vas NFr Smn |
|
|
|
N |
|
After; Ejaculate; FERTILITY TESTING; immobile; nonmotile; Number fraction; p vas; Percent; Point in time; Post vas; PST; QNT; Quan; Quant; Quantitative; Random; Sem; Seminal fluid; Smn; SMPLS; Sperm; Sperm Immotile; Spermatozoa.non-motile |
2.79 |
2.74 |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
| 101239-2 |
Mean chromosome banding resolution |
Num |
Bld/Tiss |
Pt |
Qn |
Banding |
|
ACTIVE |
Mean chromosome banding resolution [#] in Blood or Tissue by Banding |
|
MIN |
DefinitionDescription |
|
|
# |
|
|
|
|
|
|
MOLPATH.MISC |
|
101239-2 |
|
Banding |
|
|
Observation |
|
|
|
0 |
Mean chr band resolution Bld/T Banding |
|
|
|
N |
|
Average; Avg; Blood; Chromosom; Chromosomes; Cnt; Count; Mean chr band resolution; MISC; Miscellaneous molecular pathology; Molecular pathology; MOLPATH; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.75 |
2.74 |
|
|
|
|
|
|
|
{#} |
|
|
|
0 |
| 10124-6 |
ST wave displacement.mid.lead V1 |
Elpot |
Heart |
Pt |
Qn |
EKG |
|
ACTIVE |
ST wave mid displacement in lead V1 |
|
MIN |
DefinitionDescription |
|
|
mV |
|
|
|
|
|
|
EKG.MEAS |
|
10124-6 |
|
EKG |
|
|
Observation |
|
|
|
0 |
ST wave MD L-V1 |
|
|
|
Y |
|
Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Eklund; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; ST wave MD L-V1; Voltage |
2.48 |
1.0i |
|
|
|
|
|
|
|
mV |
|
|
|
0 |
| 101240-0 |
Contactin-associated protein 2 Ab |
PrThr |
Ser/Plas |
Pt |
Ord |
IF |
|
ACTIVE |
Contactin-associated protein 2 Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
101240-0 |
|
IF |
|
|
Both |
|
|
|
0 |
CASPR2 Ab SerPl Ql IF |
|
|
|
N |
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Assoc; Autoantibodies; Autoantibody; CASPR2; CASPR2 Ab; FA; Fluorescent antibody; Fluoresent; IFA; II; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Ordinal; Pl; Plasma; Plsm; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Time Resolved Fluorescence; TRF |
2.75 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101241-8 |
Contactin-associated protein 2 Ab |
PrThr |
CSF |
Pt |
Ord |
IF |
|
ACTIVE |
Contactin-associated protein 2 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
101241-8 |
|
IF |
|
|
Both |
|
|
|
0 |
CASPR2 Ab CSF Ql IF |
|
|
|
N |
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Assoc; Autoantibodies; Autoantibody; CASPR2; CASPR2 Ab; Cerebral spinal fluid; Cerebrospinal Fl; FA; Fluorescent antibody; Fluoresent; IFA; II; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Ordinal; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; TRF |
2.75 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101242-6 |
Dipeptidyl aminopeptidase-like protein 6 Ab |
PrThr |
CSF |
Pt |
Ord |
IF |
|
ACTIVE |
Dipeptidyl aminopeptidase-like protein 6 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
101242-6 |
|
IF |
|
|
Both |
|
|
|
0 |
DPPX Ab CSF Ql IF |
|
|
|
N |
|
ABS; Aby; ACIF; Amiopep; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dipeptidyl peptidase-like protein 6; Dipeptidyl peptidase-like protein 6 Ab; DPPX; DPPX Ab; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Ordinal; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; TRF |
2.75 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101243-4 |
Dipeptidyl aminopeptidase-like protein 6 Ab |
PrThr |
Ser/Plas |
Pt |
Ord |
IF |
|
ACTIVE |
Dipeptidyl aminopeptidase-like protein 6 Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
101243-4 |
|
IF |
|
|
Both |
|
|
|
0 |
DPPX Ab SerPl Ql IF |
|
|
|
N |
|
ABS; Aby; ACIF; Amiopep; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dipeptidyl peptidase-like protein 6; Dipeptidyl peptidase-like protein 6 Ab; DPPX; DPPX Ab; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Ordinal; Pl; Plasma; Plsm; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Time Resolved Fluorescence; TRF |
2.75 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101244-2 |
Leucine-rich glioma-inactivated protein 1 Ab |
PrThr |
CSF |
Pt |
Ord |
IF |
|
ACTIVE |
Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
101244-2 |
|
IF |
|
|
Both |
|
|
|
0 |
LGI1 Ab CSF Ql IF |
|
|
|
N |
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; FA; Fluorescent antibody; Fluoresent; i; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Leu; LGI1; LGI1 Ab; Ordinal; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; TRF |
2.75 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101245-9 |
Leucine-rich glioma-inactivated protein 1 Ab |
PrThr |
Ser/Plas |
Pt |
Ord |
IF |
|
ACTIVE |
Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
101245-9 |
|
IF |
|
|
Both |
|
|
|
0 |
LGI1 Ab SerPl Ql IF |
|
|
|
N |
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; FA; Fluorescent antibody; Fluoresent; i; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Leu; LGI1; LGI1 Ab; Ordinal; Pl; Plasma; Plsm; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Time Resolved Fluorescence; TRF |
2.75 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101246-7 |
N-methyl-D-aspartate receptor Ab |
PrThr |
Ser/Plas |
Pt |
Ord |
IF |
|
ACTIVE |
NMDAR Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
101246-7 |
|
IF |
|
|
Both |
|
|
|
0 |
NMDAR Ab SerPl Ql IF |
|
|
|
N |
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Asp; Aspartic acid; Autoantibodies; Autoantibody; Dextro; Encephalitis; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; NMDA receptor; NMDAR; N-Methylaspartate Receptors; N-Methyl-D-aspartic Acid; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Rec; Recept; Receptors; Recp; Recptr; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Time Resolved Fluorescence; TRF |
2.75 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101247-5 |
N-methyl-D-aspartate receptor Ab |
PrThr |
CSF |
Pt |
Ord |
IF |
|
ACTIVE |
NMDAR Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
101247-5 |
|
IF |
|
|
Both |
|
|
|
0 |
NMDAR Ab CSF Ql IF |
|
|
|
N |
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Asp; Aspartic acid; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dextro; Encephalitis; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; NMDA receptor; NMDAR; N-Methylaspartate Receptors; N-Methyl-D-aspartic Acid; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rec; Recept; Receptors; Recp; Recptr; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; TRF |
2.75 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101248-3 |
Pathologic casts |
PrThr |
Urine sed |
Pt |
Ord |
Microscopy.light |
|
ACTIVE |
Pathologic casts [Presence] in Urine sediment by Light microscopy |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
UA |
|
101248-3 |
|
Microscopy.light |
|
|
Both |
|
|
|
0 |
Path casts UrnS Ql Micro |
|
|
|
N |
|
Cast; LM; Micro; Micros; Microscopic; Ordinal; Path; Path casts; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS |
2.75 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101249-1 |
Delta-8-tetrahydrocannabinol |
MCnc |
Urine |
Pt |
Qn |
LC/MS/MS |
|
ACTIVE |
Delta-8-tetrahydrocannabinol [Mass/volume] in Urine by LC/MS/MS |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
101249-1 |
|
LC/MS/MS |
|
|
Observation |
|
|
|
0 |
Delta-8-THC Ur LC/MS/MS-mCnc |
|
|
|
N |
|
Delta(9)-THC; Delta-8-THC; Delta-9-tetrahydrocannabinol; Dronabinol; DRUG/TOXICOLOGY; Drugs; Level; Marijuana; Mass concentration; Nabilone; Point in time; QNT; Quan; Quant; Quantitative; Random; THC; UA; UR; Urn |
2.75 |
2.74 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 10125-3 |
ST wave displacement.mid.lead V2 |
Elpot |
Heart |
Pt |
Qn |
EKG |
|
ACTIVE |
ST wave mid displacement in lead V2 |
|
MIN |
DefinitionDescription |
|
|
mV |
|
|
|
|
|
|
EKG.MEAS |
|
10125-3 |
|
EKG |
|
|
Observation |
|
|
|
0 |
ST wave MD L-V2 |
|
|
|
Y |
|
Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Eklund; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; ST wave MD L-V2; Voltage |
2.48 |
1.0i |
|
|
|
|
|
|
|
mV |
|
|
|
0 |
| 101250-9 |
Aspergillus fumigatus |
PrThr |
Isolate |
Pt |
Ord |
|
|
ACTIVE |
Aspergillus fumigatus [Presence] in Isolate |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
101250-9 |
|
|
|
|
Both |
|
|
|
0 |
A fumigatus Islt Ql |
|
|
|
N |
|
A fumigatus; Asperg; Aspergil; Aspergilis; Aspergilla; Aspergillin; Aspergillosis; Aspergils; Aspergilus; Farmers lung; Fum; Islt; Isol; m003; m3; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Vet; Veterinary |
2.75 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101251-7 |
Dense fine speckled 70 protein Ab |
PrThr |
Ser/Plas |
Pt |
Ord |
|
|
ACTIVE |
Dense fine speckled 70 protein Ab [Presence] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
101251-7 |
|
|
|
|
Both |
|
|
|
0 |
DFS70 Ab SerPl Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; DFS70; Ordinal; Pl; Plasma; Plsm; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.75 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101252-5 |
Urea |
MCnc |
Dial fld |
Pt |
Qn |
|
|
ACTIVE |
Urea [Mass/volume] in Dialysis fluid |
|
MIN |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
CHEM |
|
101252-5 |
|
|
|
|
Observation |
|
|
|
0 |
Urea Dial fld-mCnc |
|
|
|
N |
|
Chemistry; Diaf; Dialysate; Dialysis fluid; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.75 |
2.74 |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
| 101253-3 |
Thrombin generation test |
Imp |
PPP |
Pt |
Nar |
|
|
ACTIVE |
Thrombin generation test [Interpretation] in Platelet poor plasma Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
COAG |
|
101253-3 |
|
|
|
|
Observation |
|
|
|
0 |
TGT PPP-Imp |
|
|
|
N |
|
COAGULATION; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; Plas; Platelet poor plasma; Point in time; Random; Report; TGT; Throm |
2.75 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101254-1 |
Herpes virus 6 DNA |
ACnc |
Ser/Plas |
Pt |
Qn |
Probe.amp.tar |
|
ACTIVE |
Herpes virus 6 DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
IU/mL |
|
|
|
|
|
|
MICRO |
|
101254-1 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
HHV6 DNA SerPl NAA+probe-aCnc |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Arbitrary concentration; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herpesvirus; HHV; HHV6; HHV-6; Human herpes virus; Human herpes virus type 6; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; PCR; Pl; Plasma; Plsm; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load |
2.75 |
2.74 |
|
|
|
|
|
|
|
[IU]/mL |
|
|
|
0 |
| 101255-8 |
Herpes virus 6 DNA |
ACnc |
Bld |
Pt |
Qn |
Probe.amp.tar |
|
ACTIVE |
Herpes virus 6 DNA [Units/volume] (viral load) in Blood by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
IU/mL |
|
|
|
|
|
|
MICRO |
|
101255-8 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
HHV6 DNA Bld NAA+probe-aCnc |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Arbitrary concentration; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herpesvirus; HHV; HHV6; HHV-6; Human herpes virus; Human herpes virus type 6; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load; WB; Whole blood |
2.75 |
2.74 |
|
|
|
|
|
|
|
[IU]/mL |
|
|
|
0 |
| 101256-6 |
Silica clotting time |
RelTime |
PPP |
Pt |
Qn |
|
|
ACTIVE |
Silica clotting time of Platelet poor plasma |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
COAG |
|
101256-6 |
|
|
|
|
Observation |
|
|
|
0 |
SCT PPP |
|
|
|
N |
|
Clot; Clottable; COAGULATION; Coagulation time; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random; Rate; RlTm; R-time; SCT; Silicon dioxide |
2.75 |
2.74 |
|
|
|
|
|
|
|
% |
|
|
|
0 |
